Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation
- PMID: 15766823
- DOI: 10.1016/j.jacc.2004.11.050
Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation
Abstract
Objectives: The aim of our study was to determine the incidence of asymptomatic recurrences of atrial fibrillation (AF) by daily transtelephonic (TT) electrocardiographic (ECG) monitoring, as compared with standard ECG and 24-h Holter recording, in patients who underwent radiofrequency catheter ablation (RCA) of AF.
Background: The efficacy of RCA of AF is usually evaluated by means of patients' symptoms.
Methods: Seventy-two patients with paroxysmal (n = 37) or persistent (n = 35) drug-refractory AF underwent circumferential RCA of the pulmonary vein (PV) ostia. Left isthmus ablation was performed in 57 patients, and cavotricuspid isthmus ablation was done in 69 patients. Patients were scheduled to obtain an ECG and Holter recordings one and four months after ablation, as well as a daily TT ECG, from 30 to 120 days after ablation or in the event of symptoms.
Results: A total of 5,585 TT ECGs were obtained (mean 77.5 per patient). In 20 patients (27.8%), AF recurrences were recorded during TT ECG, whereas ECG and Holter monitoring revealed AF recurrences in 10 patients (13.9%, p = 0.001). Ten patients had at least one asymptomatic AF recurrence, and eight were completely asymptomatic. The ECG recorded in the event of symptoms always showed AF.
Conclusions: Transtelephonic ECG is better than standard ECG and 24-h Holter recordings in evaluating AF relapses after RCA, thus decreasing the short-term success of ablation from 86% to 72%. The absence of symptoms should not be interpreted as absence of AF, as 50% of patients were asymptomatic during at least one AF episode.
Similar articles
-
Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation.J Cardiovasc Electrophysiol. 2005 Dec;16(12):1286-92. doi: 10.1111/j.1540-8167.2005.00245.x. J Cardiovasc Electrophysiol. 2005. PMID: 16403058
-
Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.Circulation. 2005 Jul 19;112(3):307-13. doi: 10.1161/CIRCULATIONAHA.104.518837. Epub 2005 Jul 11. Circulation. 2005. PMID: 16009793
-
Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation.Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S112-5. doi: 10.1111/j.1540-8159.2007.00618.x. Pacing Clin Electrophysiol. 2007. PMID: 17302684 Clinical Trial.
-
Outcome of atrial fibrillation ablation: assessment of success.Minerva Cardioangiol. 2008 Dec;56(6):635-41. Minerva Cardioangiol. 2008. PMID: 19092738 Review.
-
Ambulatory ECG monitoring in atrial fibrillation management.Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):143-52. doi: 10.1016/j.pcad.2013.10.001. Epub 2013 Oct 5. Prog Cardiovasc Dis. 2013. PMID: 24215746 Review.
Cited by
-
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.Heart Rhythm. 2012 Apr;9(4):632-696.e21. doi: 10.1016/j.hrthm.2011.12.016. Epub 2012 Mar 1. Heart Rhythm. 2012. PMID: 22386883 No abstract available.
-
Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation - the AGNES-ECG study.J Interv Card Electrophysiol. 2022 Nov;65(2):373-380. doi: 10.1007/s10840-022-01166-4. Epub 2022 Mar 3. J Interv Card Electrophysiol. 2022. PMID: 35244820 Free PMC article.
-
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12. Heart Rhythm. 2017. PMID: 28506916 Free PMC article. No abstract available.
-
How often should we monitor for reliable detection of atrial fibrillation recurrence? Efficiency considerations and implications for study design.PLoS One. 2014 Feb 12;9(2):e89022. doi: 10.1371/journal.pone.0089022. eCollection 2014. PLoS One. 2014. PMID: 24563690 Free PMC article.
-
Acupuncture versus pharmacological conversation in treatment of atrial fibrillation in a randomized controlled trial: a systemic review and meta-analysis.Eur J Med Res. 2022 Jul 4;27(1):110. doi: 10.1186/s40001-022-00738-4. Eur J Med Res. 2022. PMID: 35786416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical